Anthrax CT

Anthrax Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Anthrax from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Anthrax CT On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Anthrax CT All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Anthrax CT
CDC on Anthrax CT
Anthrax CT in the news
Blogs on Anthrax CT
Directions to Hospitals Treating Anthrax
Risk calculators and risk factors for Anthrax CT

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]

Overview

The chest CT, besides mediastinal widening, identifies hyperdense lymph nodes and edema of the mediastinal fat.

CT

Chest CT is able to identify the following changes in inhaled anthrax patients:

• Mediastinal widening (common among patients who present at a hospital emergency department)
• Hyperdense lymph nodes in the mediastinum, which represent haemorrhage and necrosis, following spore germination and vegetative growth with exotoxin elaboration
• Edema of mediastinal fat